Matthew Handley

Update To The EPO Guidelines For Examination 2024: Antibodies

Moving Apart – Diverging Approaches To Broad Functional Antibody Claims In Europe And The US

The Impact Of G2/21 On Biotech Patent Drafting – Extraordinary Claims Require Extraordinary Evidence

G3/19: EBA Finds Plants Produced By Essentially Biological Processes Are Not Patentable

President's Referral To Enlarged Board Of Appeal - Patentability Of Plants And Plant Products